Jina Jung
About
Jina Jung is a scholar working on Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Jina Jung has authored 37 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Oncology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jina Jung's work include Urinary Bladder and Prostate Research (6 papers), Sexual function and dysfunction studies (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jina Jung is often cited by papers focused on Urinary Bladder and Prostate Research (6 papers), Sexual function and dysfunction studies (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jina Jung collaborates with scholars based in South Korea, United States and United Kingdom. Jina Jung's co-authors include Hyeong‐Seok Lim, Samantha J. Eells, Megan Nguyen, Raul Macias Gil, Loren G. Miller, Larissa May, Kyun‐Seop Bae, Key H. Kim, Kiwon Jung and Dae‐Kee Kim and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Jina Jung
34 papers receiving 386 citations
Peers
Jina Jung
E. A. Platz United States
Rikard Sandström Sweden
M Zschiesche Germany
G. Peracchia Italy
Shridhar C. Ghagane India
Hannu Sundquist Finland
Fumihiko Ushigome Japan
Manasvi Gupta United States
Ganesh Rao United States
Bina Isaac India
Citations per year, relative to Jina Jung Jina Jung (= 1×)
peers
E. A. Platz
Countries citing papers authored by Jina Jung
Since
Specialization
Citations
This map shows the geographic impact of Jina Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jina Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jina Jung more than expected).
Fields of papers citing papers by Jina Jung
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jina Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jina Jung. The network helps show where Jina Jung may publish in the future.
Co-authorship network of co-authors of Jina Jung
This figure shows the co-authorship network connecting the top 25 collaborators of Jina Jung. A scholar is included among the top collaborators of Jina Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jina Jung. Jina Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jung, Jina, et al.. (2024). Evaluating the toxicity of the roots of Asarum heterotropoides var. mandshuricum extracted using the decoction method: Genotoxicity, single-dose toxicity, and 13-week repeated-dose toxicity studies. Journal of Ethnopharmacology. 325. 117783–117783.
2.
Hong, Sung Hee, et al.. (2023). Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects. Drug Design Development and Therapy. Volume 17. 1115–1124.
3.
Kim, Hyungsub, et al.. (2022). Pharmacokinetic Drug Interaction Between Amlodipine and Tadalafil: An Open-Label, Randomized, Multiple-Dose Crossover Study in Healthy Male Volunteers. SHILAP Revista de lepidopterología.
4.
Jung, Jina, et al.. (2022). Evaluation of genotoxicity and 13-week subchronic toxicity of root of Asarum heterotropoides var. seoulense (Nakai) Kitag. Journal of Ethnopharmacology. 305. 116012–116012.
5.
Yun, Yeonghun, Gill Sang Han, Jihyun Kim, et al.. (2022). A Wide Bandgap Halide Perovskite Based Self‐Powered Blue Photodetector with 84.9% of External Quantum Efficiency (Adv. Mater. 51/2022). Advanced Materials. 34(51).
6.
Jung, Jina, et al.. (2020). <p>Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers</p>. Drug Design Development and Therapy. Volume 14. 661–668.
7.
Jung, Jina, et al.. (2020). Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers. Translational and Clinical Pharmacology. 28(4). 181–181.
8.
Yu, Kyung‐Sang, et al.. (2020). Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects. International Journal of Clinical Pharmacology and Therapeutics. 58(6). 354–362.
9.
Kim, Hyungsub, Hee Youn Choi, Yohan Kim, et al.. (2018). Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers. Drug Design Development and Therapy. Volume 12. 815–821.
10.
Chung, Jae Hoon, Cheol Young Oh, Jae Heon Kim, et al.. (2018). Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial. Current Medical Research and Opinion. 34(10). 1793–1801.
11.
Park, Min Soo, et al.. (2017). Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects. Clinical Therapeutics. 39(9). 1799–1810.
12.
Han, Ji‐Youn, Ki Hyeong Lee, Sang‐We Kim, et al.. (2016). A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors. Cancer Research and Treatment. 49(1). 10–19.
13.
Yang, Seungwon, et al.. (2016). Pharmacokinetics and safety profiles of tadalafil/tamsulosin HCl fixed-dose combination capsule under fasted and fed condition in healthy volunteers. Translational and Clinical Pharmacology. 24(4). 175–175.
14.
Eells, Samantha J., David Geffen, Jina Jung, et al.. (2015). Examining the Relationship Between Adherence to Oral Antibiotics and Post-Discharge Clinical Outcomes Among Patients Hospitalized With Staphylococcus aureus Skin Infections. Open Forum Infectious Diseases. 2(suppl_1).
15.
Lee, Keun‐Wook, Kyung Hee Lee, Dae Young Zang, et al.. (2015). Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer. The Oncologist. 20(8). 896–897.
16.
Lee, J.-S., Ji‐Youn Han, Jie‐Hyun Kim, et al.. (2015). 425PD Clinical activity and safety of the EGFR mutant-specific inhibitor, BI1482694, in patients (pts) with T790M-positive NSCLC. Annals of Oncology. 26. ix125–ix125.
17.
Lim, Hyeong‐Seok, et al.. (2014). Population pharmacokinetics of HM781-36 (poziotinib), pan-human EGF receptor (HER) inhibitor, and its two metabolites in patients with advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 75(1). 97–109.
18.
Jung, Jin Ah, Sang‐Heon Cho, Jong‐Lyul Ghim, et al.. (2012). The pharmacokinetics of letrozole its association with key body mass metrics. International Journal of Clinical Pharmacology and Therapeutics. 50(8). 557–565.
19.
Lee, Saeyoung, Sung Chul Ha, Jina Jung, et al.. (2009). Crystallization and preliminary X-ray analysis of neoagarobiose hydrolase fromSaccharophagus degradans2-40. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 65(12). 1299–1301.
20.
Jung, Jina, et al.. (2006). Relation Factors of Oral Health Behavior of Junior College in Jeollanamdo. Journal of Korean society of Dental Hygiene. 6(4). 387–402.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by E. A. Platz Breakdown of academic impact, for papers by Rikard Sandström Breakdown of academic impact, for papers by M Zschiesche Breakdown of academic impact, for papers by G. Peracchia Breakdown of academic impact, for papers by Shridhar C. Ghagane Breakdown of academic impact, for papers by Hannu Sundquist Breakdown of academic impact, for papers by Fumihiko Ushigome Breakdown of academic impact, for papers by Manasvi Gupta Breakdown of academic impact, for papers by Ganesh Rao Breakdown of academic impact, for papers by Bina Isaac